Literature DB >> 8214749

Minimum alveolar concentration of desflurane in patients older than 65 yr.

M I Gold1, D Abello, C Herrington.   

Abstract

BACKGROUND: The minimum alveolar concentration (MAC) of desflurane/oxygen is 7.25% in the 18-30-yr age group, and 6.0% in the 31-65-yr age group. The addition of 60% N2O reduces MAC to 4.0 and 2.83%, respectively. Because MAC of other inhaled anesthetics is less than that for younger adults, we determined MAC of desflurane in adults aged 65 yr and older.
METHODS: Thirty-nine patients, 21 of whom received 60% N2O/O2/desflurane, and 18 of whom received desflurane/oxygen, scheduled for surgery, were enrolled. They received no premedication, intravenous induction agent, opioid, or neuromuscular blocking agent for intubation. After 10 min or more at a steady end-tidal desflurane concentration, the incision was made. In both groups, six crossover pairs of patients responses (movement-no movement) provided a mean end-tidal concentration. Minimum alveolar concentration was defined as the average of the six crossover midpoints in each subgroup.
RESULTS: MAC was 5.17 +/ 0.6% (mean +/- SD) in the desflurane/oxygen group. It was 1.67 +/- 0.4% in the desflurane/nitrous oxide/oxygen group.
CONCLUSIONS: In the geriatric patient, MAC of desflurane, with or without nitrous oxide, is less than that reported in patients aged 18-65 yr. This is in agreement with results with all other inhalation agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214749     DOI: 10.1097/00000542-199310000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Electroencephalographic effect of age-adjusted 1 MAC desflurane and sevoflurane in young, middle-aged, and elderly patients.

Authors:  Shinya Kanazawa; Yutaka Oda; Chika Maeda; Ryu Okutani
Journal:  J Anesth       Date:  2017-08-08       Impact factor: 2.078

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Desflurane requirements for laryngeal mask airway insertion during inhalation induction.

Authors:  Hwa-Yong Shin; Jung-Ae Lim; Seong-Hyop Kim; Seung-Woo Baek; Duk-Kyung Kim
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

4.  Bispectral index monitor: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

Review 5.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

6.  Unique Aspects of the Elderly Surgical Population: An Anesthesiologist's Perspective.

Authors:  Relin Yang; Matthew Wolfson; Michael C Lewis
Journal:  Geriatr Orthop Surg Rehabil       Date:  2011-03

Review 7.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

8.  Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial.

Authors:  Chengwei Yang; Fang Kang; Wenjun Meng; Meirong Dong; Xiang Huang; Sheng Wang; Zhiyi Zuo; Juan Li
Journal:  Clin Interv Aging       Date:  2021-01-15       Impact factor: 4.458

9.  Hypobaric Unilateral Spinal Anaesthesia versus General Anaesthesia in Elderly Patients Undergoing Hip Fracture Surgical Repair: A Prospective Randomised Open Trial.

Authors:  Pascal Meuret; Lionel Bouvet; Benoit Villet; Mohamed Hafez; Bernard Allaouchiche; Emmanuel Boselli
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.